{"database": "lobbying", "table": "lobbying_activities", "rows": [[1908242, "81d9d1bb-135d-4bd6-9133-e03133d46158", "Q4", "ADVANCED POLICY CONSULTING, LLC", 401103524, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)", 2016, "fourth_quarter", "MMM", "Opposition to the Center for Medicare and Medicaid Innovation's (CMMI) new Part B Drug model, which would put patient access and quality of care at risk.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2016-12-29T10:29:17.803000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1908242"], "units": {}, "query_ms": 0.3341939300298691, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}